WT 003
Alternative Names: WT-003Latest Information Update: 22 Dec 2021
At a glance
- Originator Windtree Therapeutics
- Developer Lee's Pharmaceutical; Windtree Therapeutics
- Class Cardiovascular therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase II Cardiovascular disorders
Most Recent Events
- 07 Dec 2021 Phase-II clinical trials in Cardiovascular disorders in Hong Kong (unspecified route) as of December 2021 (Lee's Pharmaceutical pipeline, December 2021)